Mortality Rates and Clinical Predictors of Reduced Survival After Cardioverter Defibrillator Implantation

American Journal of Cardiology

Volumn 101, Issue 6, 2008, Pages 861-864

  Thibodeau, Joseph B ^a   Pillarisetti, Jayasree ^a   Khumri, Taiyeb M ^a   Jones, Philip G ^a   Main, Michael L ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; OMEGA 3 FATTY ACID; WARFARIN;

ADULT; AGED; ARTICLE; DEFIBRILLATOR; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION; STATISTICAL ANALYSIS; SURVIVAL TIME;

DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; MISSOURI; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 40149099174     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.10.048     Document Type: Article

References (12)

1. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 48 (2006) 247-346
2. Esptein A.E., Baessler C.A., Curtis A.B., Estes M.A., Gersh B.J., Grubb B., and Mitchell L.B. Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology.". Public safety issues in patients with implantable defibrillators: a scientific statement from the American Heart Association and the Heart Rhythm Society. Heart Rhythm 4 (2007) 386-393
3. Harrell F.E. Regression Modeling Strategies, with Applications to Linear Models, Survival Analysis and Logistic Regression (2001), Springer, New York
4. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing (2006). http://www.R-project.org Accessed on January 8, 2008
5. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
6. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., and Andrews M.L. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction: MADIT-II. N Engl J Med 346 (2002) 877-883
7. Curtis J.P., Sokol S.I., Wang Y., Rathore S.S., Ko D.T., Jadbabaie F., Portnay E.L., Mashalko S.J., Radford M.J., and Krumholz H.M. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol 42 (2003) 736-742
8. The Candesartan in Heart Failure Reduction in Mortality (CHARM) investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112 (2005) 3738-3744
9. Rathore S.S., Curtis J.P., Wang Y., Bristow M.R., and Krumholz H.M. Association of serum digoxin concentrations and outcomes in patients with heart failure. JAMA 289 (2003) 871-878
10. Moss A.J., Hall W.J., Cannon D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., and Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 (1996) 1933-1940
11. Buxton A.E., Fisher J.D., Josephson M.E., Lee K.L., Pryor D.B., Prystowski E.N., Simson M.B., DiCarlo L., Echt D.S., and Packer D. Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT). Prog Cardiovasc Dis 36 (1993) 215-226
12. Connolly S.J., Gent M., Roberts R.S., Dorian P., Roy D., Sheldon R.S., Mitchell L.B., Green M.S., Klein G.J., and O'Brien B. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 (2000) 1297-1302